Search





Search





LENZ Therapeutics Inc

LENZ

Add to Watchlist

3.710USD

-0.050-1.33%

Market hours 09/24, 14:32（ET）

116.31MMarket Cap

LossP/E TTM

LENZ Therapeutics Inc

3.710

-0.050-1.33%

Financial Summary Income Statement Balance Sheet Cash Flow Statement Earnings Company Valuation Risk Assessment

Overview

News&Analysis

Financials

Stock Score

Technical

Forecast

Ownership

Dividends

Profile

Discussions

Financial Summary Income Statement Balance Sheet Cash Flow Statement Earnings Company Valuation Risk Assessment

LENZ Cash Flow Statement

You can access the annual and quarterly cash flow statements of LENZ Therapeutics Inc to evaluate its financial soundness and stability.

Quarterly

Quarterly+Annual

Quarterly

Annual

YOY

Hide blank rows

FY2026Q2

FY2026Q1

FY2025Q4

FY2025Q3

FY2025Q2

FY2025Q1

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022Q4

FY2022Q3

FY2022Q2

FY2022Q1

FY2021Q4

FY2021Q3

FY2021Q2

FY2021Q1

FY2020Q4

FY2020Q3

FY2020Q2

FY2020Q1

Operating cash flows (indirect method)

Cash flow from continuing operating activities

-236.40%-38.71M

-109.25%-33.58M

-263.79%-33.02M

18.84%-8.59M

27.14%-11.51M

32.95%-16.05M

80.21%-9.08M

-12.55%-10.58M

-15.67%-15.79M

-13.59%-23.94M

-104.54%-45.88M

57.69%-9.40M

38.20%-13.65M

0.78%-21.07M

-43.84%-22.43M

-44.13%-22.22M

-60.29%-22.09M

-163.52%-21.24M

-195.83%-15.59M

-518.33%-15.41M

-1346.38%-13.78M

-201400.00%-8.06M

---5.27M

---2.49M

---953.00K

---4.00K

Net income from continuing operations

-114.04%-31.92M

-183.80%-41.49M

-183.72%-35.90M

-63.49%-16.70M

-45.43%-14.91M

12.19%-14.62M

44.79%-12.65M

54.57%-10.21M

81.46%-10.25M

30.44%-16.65M

6.83%-22.92M

8.90%-22.48M

-113.27%-55.31M

7.36%-23.93M

-29.95%-24.60M

-69.15%-24.68M

-47.96%-25.94M

-31.08%-25.84M

70.21%-18.93M

-331.21%-14.59M

-1236.05%-17.53M

-13878.01%-19.71M

---63.54M

---3.38M

---1.31M

---141.00K

Operating gains losses

478.95%110.00K

-5.93%111.00K

328.00%107.00K

1150.00%125.00K

5.56%19.00K

2260.00%118.00K

-99.81%25.00K

-99.87%10.00K

-99.95%18.00K

-99.24%5.00K

1877.57%13.49M

1123.47%7.98M

6285.81%36.91M

48.64%654.00K

106.67%682.00K

229.29%652.00K

398.28%578.00K

388.89%440.00K

334.21%330.00K

350.00%198.00K

11500.00%116.00K

--90.00K

--76.00K

--44.00K

--1.00K

--0.00

Other non-cash items

87.39%-112.00K

30.25%-791.00K

-176.26%-3.93M

-27.15%-1.73M

7.40%-888.00K

-246.89%-1.13M

-126.40%-1.42M

-1626.97%-1.36M

-377.97%-959.00K

19200.00%772.00K

1187.35%5.39M

-90.67%89.00K

-77.36%345.00K

-99.73%4.00K

-62.05%419.00K

167.98%954.00K

--1.52M

-85.52%1.50M

-98.10%1.10M

193.68%356.00K

--0.00

--10.34M

--57.98M

---380.00K

--0.00

Change in working capital

-888.87%-11.27M

243.72%4.27M

-15.15%2.82M

617.05%6.25M

123.04%1.43M

67.06%-2.97M

107.82%3.33M

-196.72%-1.21M

-298.88%-6.20M

-749.48%-9.01M

-1565.77%-42.53M

153.13%1.25M

292.35%3.12M

-55.12%-1.06M

-370.17%-2.55M

37.32%-2.35M

-200.56%-1.62M

-469.73%-684.00K

-948.44%-543.00K

-414.95%-3.75M

378.04%1.61M

58.12%185.00K

--64.00K

--1.19M

--337.00K

--117.00K

-Change in receivables

---99.00K

---14.00K

---329.00K

----

-Change in prepaid expenses

-1187.50%-2.58M

65.76%-341.00K

-371.37%-1.92M

132.63%93.00K

-268.07%-200.00K

-92.28%-996.00K

-10.48%709.00K

87.19%-285.00K

-97.89%119.00K

-135.55%-518.00K

202.33%792.00K

24.93%-2.23M

845.15%5.65M

2152.11%1.46M

-171.14%-774.00K

18.55%-2.96M

32.01%598.00K

96.09%-71.00K

205.73%1.09M

-3599.04%-3.64M

225.48%453.00K

---1.82M

---1.03M

--104.00K

---361.00K

--0.00

-Change in other current assets

109.80%20.00K

--1.00K

--203.00K

--0.00

85.19%-204.00K

----

--0.00

---1.38M

----

-Change in other current liabilities

--785.00K

----

--64.00K

----

Cash from non-recurring investing activities

Cash from operating activities

-236.40%-38.71M

-109.25%-33.58M

-263.79%-33.02M

18.84%-8.59M

27.14%-11.51M

32.95%-16.05M

80.21%-9.08M

-12.55%-10.58M

-15.67%-15.79M

-13.59%-23.94M

-104.54%-45.88M

57.69%-9.40M

38.20%-13.65M

0.78%-21.07M

-43.84%-22.43M

-44.13%-22.22M

-60.29%-22.09M

-163.52%-21.24M

-195.83%-15.59M

-518.33%-15.41M

-1346.38%-13.78M

-201400.00%-8.06M

---5.27M

---2.49M

---953.00K

---4.00K

Investing cash flow

Net cash from continuing investing activities

-93.33%16.00K

-83.64%18.00K

-74.50%38.00K

136.02%439.00K

80.45%240.00K

--110.00K

123.69%149.00K

-95.26%186.00K

-97.48%133.00K

-100.00%0.00

-161.61%-629.00K

328.96%3.92M

280.72%5.27M

-88.30%383.00K

4.08%1.02M

-74.83%915.00K

81.52%1.39M

809.17%3.27M

60.29%981.00K

556.32%3.64M

101.32%763.00K

--360.00K

--612.00K

--554.00K

--379.00K

--0.00

Capital expenditures

-93.33%16.00K

-83.64%18.00K

-74.50%38.00K

136.02%439.00K

80.45%240.00K

--110.00K

198.00%149.00K

-96.14%186.00K

-97.63%133.00K

-100.00%0.00

-95.10%50.00K

426.01%4.81M

305.05%5.61M

-88.30%383.00K

4.08%1.02M

-74.83%915.00K

81.52%1.39M

809.17%3.27M

60.29%981.00K

556.32%3.64M

101.32%763.00K

--360.00K

--612.00K

--554.00K

--379.00K

--0.00

Net cash flow from disposal of fixed assets

-93.33%16.00K

-83.64%18.00K

-74.50%38.00K

136.02%439.00K

80.45%240.00K

--110.00K

123.69%149.00K

-95.26%186.00K

-97.48%133.00K

-100.00%0.00

-161.61%-629.00K

328.96%3.92M

280.72%5.27M

-88.30%383.00K

4.08%1.02M

-74.83%915.00K

81.52%1.39M

809.17%3.27M

60.29%981.00K

556.32%3.64M

101.32%763.00K

--360.00K

--612.00K

--554.00K

--379.00K

--0.00

Net cash flow from investment products

21806.90%37.77M

74.64%33.18M

-666.37%-89.77M

93.72%-3.89M

99.82%-174.00K

5.55%19.00M

-125.22%-11.71M

-191.50%-62.04M

-226.78%-98.26M

-58.66%18.00M

219.37%46.45M

1437.07%67.80M

189.25%77.50M

126.01%43.55M

--14.54M

--4.41M

---86.83M

---167.39M

----

Net cash flow from other investing activities

--0.00

----

--1.00K

----

Cash from non-current investing activities

Net cash flow from investing activities

9219.32%37.75M

75.56%33.16M

-657.06%-89.81M

93.04%-4.33M

99.58%-414.00K

4.94%18.89M

-125.20%-11.86M

-197.42%-62.23M

-236.23%-98.39M

-58.30%18.00M

248.14%47.08M

1727.09%63.88M

181.87%72.23M

125.29%43.16M

1478.59%13.52M

196.15%3.50M

-11461.86%-88.22M

-47307.22%-170.67M

-60.29%-981.00K

-556.32%-3.64M

-101.32%-763.00K

---360.00K

---612.00K

---554.00K

---379.00K

--0.00

Financing cash flow

Cash flow from continuous financing activities

-98.51%395.00K

-68.18%14.00K

231249.06%122.61M

-97.99%598.00K

1339.49%26.49M

-99.97%44.00K

-19.70%53.00K

372625.00%29.82M

-1823.39%-2.14M

2140950.00%171.27M

-72.95%66.00K

113.56%8.00K

-69.90%124.00K

---8.00K

-22.04%244.00K

-100.19%-59.00K

-99.81%412.00K

-100.00%0.00

-97.93%313.00K

76028.57%31.89M

1363.51%219.50M

--165.77M

--15.12M

---42.00K

--15.00M

--0.00

Net cash flow from debt Issuance/repayment

----

--0.00

----

--0.00

--5.00M

----

Net cash flow from common stock issuance/repurchase

----

143255.29%121.68M

-100.00%0.00

831.60%26.07M

-100.00%0.00

---85.00K

--29.77M

-2369.43%-3.56M

--53.39M

-100.00%0.00

--0.00

-62.08%157.00K

----

-20.92%242.00K

-100.00%0.00

-99.81%414.00K

-100.00%0.00

59.38%306.00K

46117.39%31.89M

--219.45M

--268.00K

--192.00K

--69.00K

--0.00

Net cash flow from preferred stock issuance/repurchase

----

--0.00

----

--0.00

----

--0.00

----

-100.00%0.00

100.00%0.00

-101.11%-111.00K

--165.63M

--14.93M

---111.00K

--10.00M

--0.00

Proceeds from stock option exercised by employees

-6.18%395.00K

-68.18%14.00K

576.09%933.00K

949.12%598.00K

-87.66%421.00K

-89.77%44.00K

109.09%138.00K

256.25%57.00K

18861.11%3.41M

--430.00K

3200.00%66.00K

220.00%16.00K

38.46%18.00K

----

-71.43%2.00K

--5.00K

-38.10%13.00K

----

--7.00K

--0.00

--21.00K

----

Net cash flow from other financing activities

--395.00K

--0.00

100.00%0.00

-100.00%0.00

--0.00

-62.50%-13.00K

-3796.08%-1.99M

1468237.50%117.45M

--0.00

87.50%-8.00K

-240.00%-51.00K

---8.00K

--0.00

---64.00K

-111.28%-15.00K

100.00%0.00

----

--133.00K

---133.00K

----

--0.00

Net cash from non-recurrent financing activities

Net cash from financing activities

-98.51%395.00K

-68.18%14.00K

231249.06%122.61M

-97.99%598.00K

1339.49%26.49M

-99.97%44.00K

-19.70%53.00K

372625.00%29.82M

-1823.39%-2.14M

2140950.00%171.27M

-72.95%66.00K

113.56%8.00K

-69.90%124.00K

---8.00K

-22.04%244.00K

-100.19%-59.00K

-99.81%412.00K

-100.00%0.00

-97.93%313.00K

76028.57%31.89M

1363.51%219.50M

--165.77M

--15.12M

---42.00K

--15.00M

--0.00

Net cash flow

Beginning cash balance

6.98%24.77M

24.21%25.18M

-38.29%25.40M

-55.17%37.72M

-88.45%23.16M

-42.31%20.27M

-77.72%41.16M

-35.38%84.15M

180.27%200.47M

-28.93%35.14M

217.87%184.70M

69.37%130.22M

-61.71%71.53M

-86.94%49.45M

-85.29%58.11M

-79.88%76.89M

5.43%186.79M

1810.95%378.69M

3633.37%394.95M

2695.68%382.11M

8858100.00%177.16M

330183.33%19.82M

--10.58M

--13.67M

--2.00K

--6.00K

Current period cash flow changes

-103.87%-564.00K

-114.11%-407.00K

98.95%-220.00K

71.33%-12.32M

112.52%14.57M

-98.26%2.88M

-1743.43%-20.89M

-178.90%-42.99M

-298.18%-116.32M

648.75%165.33M

114.67%1.27M

390.11%54.48M

153.41%58.70M

111.51%22.08M

46.74%-8.66M

-246.27%-18.78M

-153.62%-109.90M

-221.96%-191.91M

-276.02%-16.26M

515.64%12.84M

1399.71%204.95M

3933775.00%157.35M

--9.24M

---3.09M

--13.67M

---4.00K

Ending cash balance

-35.83%24.21M

6.98%24.77M

24.21%25.18M

-38.29%25.40M

-55.17%37.72M

-88.45%23.16M

-89.10%20.27M

-77.72%41.16M

-35.38%84.15M

180.27%200.47M

276.12%185.97M

217.87%184.70M

69.37%130.22M

-61.71%71.53M

-86.94%49.45M

-85.29%58.11M

-79.88%76.89M

5.43%186.79M

1810.95%378.69M

3633.37%394.95M

2695.68%382.11M

8858100.00%177.16M

--19.82M

--10.58M

--13.67M

--2.00K

Free cash flow

-229.66%-38.73M

-107.93%-33.60M

-258.33%-33.06M

16.16%-9.03M

26.24%-11.75M

32.49%-16.16M

79.91%-9.23M

24.25%-10.77M

17.32%-15.93M

-11.56%-23.94M

-95.85%-45.93M

38.55%-14.21M

17.95%-19.27M

12.47%-21.46M

-41.49%-23.45M

-21.42%-23.13M

-61.40%-23.48M

-191.13%-24.51M

-181.73%-16.57M

-525.24%-19.05M

-992.12%-14.55M

-210400.00%-8.42M

---5.88M

---3.05M

---1.33M

---4.00K

Currency unit

--USD

Audit opinions

----

FAQs

What is operating cash flow?



Operating cash flow is the cash generated or used by a company's core business operations. It adjusts net income for non-cash items and working capital changes, such as depreciation, receivables, inventory, and payables. Strong operating cash flow can indicate that the business is converting sales and earnings into real cash.

How Much Operating Cash Flow Did LENZ Therapeutics Inc Generate?



LENZ Therapeutics Inc generated -69.17M in operating cash flow in fiscal 2025, reflecting cash generated from its core business operations.

How Did LENZ Therapeutics Inc's Operating Cash Flow Change Year Over Year?



LENZ Therapeutics Inc's operating cash flow increased by -16.47% year over year.

What is investing cash flow?



Investing cash flow shows cash used for or generated from investment-related activities, such as capital expenditures, purchases or sales of investments, acquisitions, and asset disposals. Negative investing cash flow is not always bad, because it can reflect spending on future growth, but investors should check whether those investments support long-term returns.

How Much Does LENZ Therapeutics Inc Spend on Capital Expenditures?



LENZ Therapeutics Inc spent 827.00K on capital expenditures in the most recent quarter。

What is financing cash flow?



Financing cash flow shows how a company raises capital or returns capital to investors and creditors. It can include debt issuance, debt repayment, share issuance, share repurchases, dividend payments, and lease financing. Positive financing cash flow may show new capital raised, while negative financing cash flow may reflect debt repayment, dividends, or buybacks.

How Has LENZ Therapeutics Inc's Financing Cash Flow Changed?



LENZ Therapeutics Inc used 149.75M in financing activities in the latest quarter.

What is free cash flow and why does it matter for LENZ?



Free cash flow is the cash a company has left after funding the capital spending needed to maintain or grow the business. It is often used to assess financial flexibility, debt repayment capacity, dividend sustainability, buyback potential, and valuation quality. Investors should compare free cash flow with net income, revenue growth, and capital expenditures.

What was LENZ Therapeutics Inc’s free cash flow in the latest quarter?



Free cash flow was -70.00M reflecting a -16.94% change from the previous year.